⌘K

Login Start Free

Home/Filings/4/0000899243-22-039014

4//SEC Filing

Hegde Priti 4

Accession 0000899243-22-039014

CIK 0001750019other

View on SEC.gov Company Profile

Filed

Dec 18, 7:00 PM ET

Accepted

Dec 19, 5:18 PM ET

Size

5.3 KB

Accession

0000899243-22-039014

Insider Transaction Report

Form 4

Period: 2022-12-15

TCR2 THERAPEUTICS INC.TCRR

Director

Transactions

Award
Stock Option (Right to Buy)
2022-12-15+16,800→ 16,800 total
Exercise: $0.97Exp: 2032-12-14→ Common Stock (16,800 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in twenty-four (24) equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1

filerCIK 0001880034

Filing Metadata

Form type: 4
Filed: Dec 18, 7:00 PM ET
Accepted: Dec 19, 5:18 PM ET
Size: 5.3 KB

View on SEC.gov